Susanne Meline
CIK 1731684 · last filed 2025-12-23
Susanne Meline is a corporate insider who has filed 29 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider exercised options covering $34.0K of MDBH on Dec 23, 2025. Across all open-market trades the lifetime net is +$63.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $124.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$124.6K
4
29
$63.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDBH | Director | 30,000 | $3.05 | $91.5K | $0 | 2 | 2025-12-23 |
| Catheter Precision, Inc. (RMED) Delisted | Director | 836 | $0.59 | $497 | $0 | 3 | 2023-03-27 |
| CLIR | Director | 8,152 | $4.04 | $32.9K | $60.0K | 20 | 2023-01-04 |
| AQMS | Director | 57 | $2.80 | $160 | $3.1K | 4 | 2020-01-07 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-23 | MDBH | Exer (M) | +10,000 | $34.0K | EDGAR |
| 2024-12-20 | MDBH | Exer (M) | +20,000 | $136.2K | EDGAR |
| 2023-03-27 | Catheter Precision, Inc. (RMED) Delisted | Mixed | +2,575 | $0 | EDGAR |
| 2023-01-04 | CLIR | Grant (A) | — | $0 | EDGAR |
| 2022-10-04 | CLIR | Grant (A) | — | $0 | EDGAR |
| 2022-07-06 | CLIR | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | CLIR | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | CLIR | Grant (A) | — | $0 | EDGAR |
| 2021-11-18 | CLIR | Grant (A) | — | $0 | EDGAR |
| 2021-08-26 | CLIR | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.